Xeroderma pigmentosum - Bridging a gap between clinic and laboratory

Photodermatology Photoimmunology and Photomedicine

Volumn 17, Issue 2, 2001, Pages 47-54

  Moriwaki, Shin Ichi ^a   Kraemer, Kenneth H ^b  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

CAT assay; DNA damage; DNA repair; Host cell reactivation; Skin cancer; Ultraviolet radiation

Indexed keywords

ADENINE; ALPHA INTERFERON; DNA; GUANINE; ISOTRETINOIN; NUCLEOTIDE; POLYDEOXYRIBONUCLEOTIDE SYNTHASE;

ASSAY; AUTORADIOGRAPHY; AUTOSOMAL RECESSIVE DISORDER; CELL ACTIVATION; CHROMOSOME VARIANT; CHROMOSOME XP; CLINICAL PRACTICE; COCKAYNE SYNDROME; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DAMAGE; DNA REPAIR; DNA TRANSCRIPTION; DRUG EFFICACY; EARLY DIAGNOSIS; EXCISION REPAIR; GENE ISOLATION; GENETIC ANALYSIS; GENETIC COMPLEMENTATION; GENOME; HETEROZYGOTE DETECTION; HOST CELL; HUMAN; INCIDENCE; JAPAN; LABORATORY DIAGNOSIS; MOLECULAR BIOLOGY; MOLECULAR CLONING; NEUROLOGIC DISEASE; PATHOGENESIS; PHOTOSENSITIVITY DISORDER; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROKARYOTE; PROTECTIVE CLOTHING; RADIATION EXPOSURE; RADIATION PROTECTION; REVIEW; SKIN CANCER; SKIN PROTECTION; SUNLIGHT PROTECTION; ULTRAVIOLET RADIATION; XERODERMA PIGMENTOSUM;

COCKAYNE SYNDROME; DNA DAMAGE; DNA REPAIR; GENETIC TECHNIQUES; HAIR DISEASES; HETEROZYGOTE; HUMANS; MUTATION; PHOTOSENSITIVITY DISORDERS; ULTRAVIOLET RAYS; XERODERMA PIGMENTOSUM;

EID: 0035057195     PISSN: 09054383     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0781.2001.017002047.x     Document Type: Review

References (42)

1. Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases
2. The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm
3. A case of xeroderma pigmentosum complementation group F with neurological abnormalities
4. Xeroderma pigmentosum and related disorders: Examining the linkage between defective DNA repair and cancer
5. Common pathways for ultraviolet skin carcinogenesis in the repair and replication defective groups of xeroderma pigmentosum
6. Defective transcription-coupled repair of oxidative base damage in Cockayne syndrome patients from XP group G
7. In vitro repair of oxidative DNA damage by human nucleotide excision repair system: Possible explanation for neurodegeneration in xeroderma pigmentosum patients
8. Nucleotide excision repair syndromes: Xeroderma pigmentosum, Cockayne syndrome, and trichothiodystrophy
9. A newly identified patient with clinical xeroderma pigmentosum phenotype has a nonsense mutation in the DDB2 gene and incomplete repair in (6-4) photoproducts
10. Xeroderma pigmentosum and the role of UV-induced DNA damage in skin cancer
11. Defective repair replication of DNA in xeroderma pigmentosum
12. Molecular cloning of a mouse DNA repair gene that complements the defect of group-A xeroderma pigmentosum
13. Analysis of a human DNA excision repair gene involved in group A xeroderma pigmentosum and containing a zinc-finger domain
14. Characterization of a splicing mutation in group A xeroderma pigmentosum
15. Identification of splicing mutation of the last nucleotides of exons, a nonsense mutation, and a missense mutation of the XPAC gene as causes of group A xeroderma pigmentosum
16. Three nonsense mutations responsible for group A xeroderma pigmentosum
17. Molecular basis of group A xeroderma pigmentosum: A missense mutation and two deletions located in a zinc finger consensus sequence of the XPAC gene
18. A case of xeroderma pigmentosum group A diagnosed with a polymerase chain reaction (PCR) technique. Usefulness of PCR in the detection of point mutation in a patient with a hereditary disease
19. Gene alterations and clinical characteristics of xeroderma pigmentosum group A patients in Japan
20. Aberrant splicing and truncated-protein expression due to a newly identified XPA gene mutation
21. Compound heterozygous group A xeroderma pigmentosum patient with a novel mutation and an inherited reciprocal translocation
22. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms
23. High prevalence of the point mutation in exon 6 of the xeroderma pigmentosum group A-complementing (XPAC) gene in xeroderma pigmentosum group A patients in Tunisia
24. Development of a new easy complementation assay for DNA repair deficient human syndromes using cloned repair genes
25. Xeroderma pigmentosum group C splice mutation associated with autism and hypoglycemia
26. The effect of donor age on the processing of UV-damaged DNA by cultured human cells: Reduced DNA repair capacity and increased DNA mutability
27. Neurological disease in xeroderma pigmentosum. Documentation of a late onset type of the juvenile onset form
28. DNA repair and ultraviolet mutagenesis in cells from a new patient with xeroderma pigmentosum group G and Cockayne syndrome resemble xeroderma pigmentosum cells
29. UVs syndrome, a new general category of photosensitive disorder with defective DNA repair, is distinct from xeroderma pigmentosum variant and rodent complementation group I
30. A new UV-sensitive syndrome not belonging to any complementation groups of xeroderma pigmentosum or Cockayne syndrome: Siblings showing biochemical characteristics of Cockayne syndrome without typical clinical manifestations
31. Heterozygous manifestations in four autosomal recessive human cancer-prone syndromes: Ataxia telangiectasia, xeroderma pigmentosum, Fanconi anemia, and Bloom syndrome
32. PCR-RFLP analysis as an aid to genetic counseling of families of Japanese patients with group A xeroderma pigmentosum
33. Absence of DNA repair deficiency in the confirmed heterozygotes of xeroderma pigmentosum group A
34. Ultraviolet-induced chromosomal instability in cultured fibroblasts of heterozygote carriers for xeroderma pigmentosum
35. Chromosome rearrangements in normal fibroblasts from xeroderma pigmentosum homozygotes and heterozygotes
36. Relative susceptibilities of XPA knockout mice and their heterozygous and wildtype littermates to UVB-induced skin cancer
37. Defective nucleotide excision repair in XPC mutant mice and its association with cancer predisposition
38. Clearing of melanoma in situ with intralesional interferon alpha in a patient with xeroderma pigmentosum
39. Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin
40. Enzyme therapy of xeroderma pigmentosum: Safety and efficacy testing of T4N5 liposome lotion containing a prokaryotic DNA repair enzyme
41. Topical treatment with liposomes containing T4 endonuclease V protects human skin in vivo from ultraviolet-induced upregulation of interleukin-10 and tumor necrosis factor-alpha
42. Functional retroviral vector for gene therapy of xeroderma pigmentosum group D patients